Larimar Therapeutics (LRMR) Operating Income: 2014-2020
Historic Operating Income for Larimar Therapeutics (LRMR) over the last 6 years, with Mar 2020 value amounting to -$3.6 million.
- Larimar Therapeutics' Operating Income rose 73.16% to -$3.6 million in Q1 2020 from the same period last year, while for Mar 2020 it was -$35.9 million, marking a year-over-year increase of 38.77%. This contributed to the annual value of -$45.7 million for FY2019, which is 25.31% up from last year.
- Per Larimar Therapeutics' latest filing, its Operating Income stood at -$3.6 million for Q1 2020, which was up 51.06% from -$7.3 million recorded in Q4 2019.
- In the past 5 years, Larimar Therapeutics' Operating Income registered a high of -$3.6 million during Q1 2020, and its lowest value of -$17.9 million during Q1 2016.
- Over the past 3 years, Larimar Therapeutics' median Operating Income value was -$13.3 million (recorded in 2019), while the average stood at -$12.3 million.
- Per our database at Business Quant, Larimar Therapeutics' Operating Income tumbled by 34.87% in 2016 and then soared by 73.16% in 2020.
- Larimar Therapeutics' Operating Income (Quarterly) stood at -$10.5 million in 2016, then decreased by 27.52% to -$13.4 million in 2017, then fell by 9.98% to -$14.7 million in 2018, then surged by 50.44% to -$7.3 million in 2019, then soared by 73.16% to -$3.6 million in 2020.
- Its Operating Income stands at -$3.6 million for Q1 2020, versus -$7.3 million for Q4 2019 and -$12.9 million for Q3 2019.